Synthesis and drug release in vitro of porphyran carrying 5-Fluorouracil

[1]  G. Aridoss,et al.  Synthesis and antimicrobial activities of N-chloroacetyl-2,6-diarylpiperidin-4-ones , 2007, Medicinal Chemistry Research.

[2]  Yueqing Gu,et al.  The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Quanbin Zhang,et al.  Degradation of porphyran from Porphyra haitanensis and the antioxidant activities of the degraded porphyrans with different molecular weight. , 2006, International journal of biological macromolecules.

[4]  Xiabin Jing,et al.  Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate. , 2005, Biomaterials.

[5]  H. Kammer,et al.  Solvation in Cellulose-LiCl-DMAc Solutions , 1996 .

[6]  James N. BeMiller,et al.  (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships , 1995 .

[7]  S. Suzuki,et al.  Antitumor Activity of Chitosan and Chitin Immobilized 5-Fluorouracils through Hexamethylene Spacers via Carbamoyl Bonds , 1989 .

[8]  T. Ouchi,et al.  Synthesis and antitumor activity of chitosan carrying 5-fluorouracils , 1989 .

[9]  N. Uchida,et al.  Extraction of porphyran from Porphyra yezoensis Ueda F. narawaensis Miura. , 1988 .

[10]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[11]  Ko Suzuki,et al.  Effect of N‐Acetylchito‐Oligosaccharides on Activation of Phagocytes , 1986, Microbiology and immunology.

[12]  T. Ouchi,et al.  Synthesis of poly(ethylene glycol)‐bound 3‐(5‐fluorouracil‐1‐yl)propanoic acid, its hydrolysis reactivity and antitumor activity , 1985 .

[13]  M. Sommerfeld,et al.  The Galactan Sulphates of the Conchocelis Phases of Porphyra leucostricta and Bangia atropurpurea (Rhodophyta) , 1983 .

[14]  C. Myers.  The pharmacology of the fluoropyrimidines. , 1981, Pharmacological reviews.

[15]  G. Bounous,et al.  Enhanced 5-F.U. mortality in rats eating definded formula diets. , 1978, International journal of clinical pharmacology and biopharmacy.

[16]  J. Steele,et al.  Chloroacetylation of 1-Azaphenothiazine , 1972 .

[17]  R. Woodman,et al.  Selective aggregation of L1210 leukemia cells by the polycation chitosan. , 1971, Journal of the National Cancer Institute.

[18]  J. Munson,et al.  Hydroxamic acids. I. Factors affecting the stability of the hydroxamic acid-iron complex. , 1969, Journal of pharmaceutical sciences.

[19]  Giller Sa,et al.  [Analogs of pyrimidine nucleosides. I. N1-(alpha-furanidyl) derivatives of natural pyrimidine bases and their antimetabolities]. , 1967 .

[20]  D. A. Shirley,et al.  The Friedel-Crafts acetylation and chloroacetylation of the benzophenothiazines. , 1967, The Journal of organic chemistry.

[21]  J. Holland,et al.  Experiments with some mouse tumors and leukemias. , 1958, Cancer research.

[22]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. IV. Effects on nucleic acid metabolism in vivo. , 1958, Cancer research.